Magenta Therapeutics, Inc. Gains 32.2%

Wed, May 18, 2022 at 05:30 PM
Magenta Therapeutics, Inc. Gains 32.2%

Magenta Therapeutics, Inc. (MGTA:NASDAQ) jumped higher at $1.56, a gain of 32.2%. The stock got featured on our News Catalysts scanner on Mon, May 16, 2022 at 04:55 PM in the 'BIOTECH' category. From Wed, May 04, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days

About Magenta Therapeutics, Inc. (MGTA:NASDAQ)

Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to bring the curative power of bone marrow transplant.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.